Advertisement
AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


AJPH First Look, published online ahead of print Apr 26, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2003.035485v1
95/5/900    most recent
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wise, M. E
Right arrow Articles by Sorvillo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wise, M. E
Right arrow Articles by Sorvillo, F.
©
American Journal of Public Health, 10.2105/AJPH.2003.035485


Research and Practice

Hepatitis A-Related Mortality in California, 1989-2000: Analysis of Multiple Cause-Coded Death Data

Matthew E Wise 1* Frank Sorvillo 2

1 UCLA School of Public Health
2 Los Angeles County Department of Health Services

* To whom correspondence should be addressed. E-mail: carter78{at}aol.com.


   Abstract

Objectives: To estimate the hepatitis A (HA) mortality rate in California, to assess demographic disparities in HA-related mortality, and to examine co-morbidities listed on the death certificate. Methods: HA-related deaths occurring in California from 1989 to 2000 were identified using multiple-cause-of-death files and mortality rates and rate ratios were calculated. Results: Four-hundred and two deaths were identified over the study period, representing an annual age-adjusted HA-related mortality rate of 1.20 deaths per 1,000,000 persons. Older people, males, Latinos, and Native Americans/Alaska Natives demonstrated elevated mortality rates. Liver conditions and non-A viral hepatitis infections were more common among HA-related deaths than all other deaths. Conclusions: Reevaluation of current immunization practices should be undertaken and consideration should be given to expanding current vaccination guidelines for groups with elevated HA-related mortality.

Key Words: Immunization/Vaccines, Hepatitis, Mortality







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Public Health Association